Search research articles
Contact Us
Filters
Showing results (11-20 of 85) with videos related to
Page
of 9
Sort By:
Reviews in Medical Virology
|
May 20, 2006
Vaccinia virus proteolysis--a review
Chelsea M Byrd, Dennis E Hruby
Methods in Molecular Biology (Clifton, N.J.)
|
June 13, 2012
Screening for vaccinia virus egress inhibitors: separation of IMV, IEV, and EEV
Chelsea M Byrd, Dennis E Hruby
Antiviral Research
|
September 4, 2007
Discovery and development of antiviral drugs for biodefense: experience of a small biotechnology company
Tove C Bolken, Dennis E Hruby
Biochemistry
|
June 30, 2004
Sequence-independent acylation of the vaccinia virus A-type inclusion protein
Jennifer D Yoder, Tsefang Chen, Dennis E Hruby
Future Virology
|
August 13, 2011
Development of the small-molecule antiviral ST-246 as a smallpox therapeutic
Douglas W Grosenbach, Robert Jordan, Dennis E Hruby
Biotechniques
|
May 22, 2002
BiZyme: a novel fusion protein-mediating selection of vaccinia virus recombinants by fluorescence and antibiotic resistance
Scott G Hansen, Torrey A Cope, Dennis E Hruby
Journal of Virology
|
August 7, 2002
The vaccinia virus I7L gene product is the core protein proteinase
Chelsea M Byrd, Tove' C Bolken, Dennis E Hruby
Virology Journal
|
September 2, 2006
Analysis of vaccinia virus temperature-sensitive I7L mutants reveals two potential functional domains
Megan J Moerdyk, Chelsea M Byrd, Dennis E Hruby
Journal of Virology
|
September 27, 2003
Molecular dissection of the vaccinia virus I7L core protein proteinase
Chelsea M Byrd, Tove' C Bolken, Dennis E Hruby
Virology Journal
|
March 1, 2006
Mutational analysis of the potential catalytic residues of the VV G1L metalloproteinase
Kady M Honeychurch, Chelsea M Byrd, Dennis E Hruby
Page
of 9
Search research articles
Search
Showing results (11-20 of 85) with videos related to
Sort By:
Page
of 9
Reviews in Medical Virology
|
May 20, 2006
Vaccinia virus proteolysis--a review
Chelsea M Byrd, Dennis E Hruby
Methods in Molecular Biology (Clifton, N.J.)
|
June 13, 2012
Screening for vaccinia virus egress inhibitors: separation of IMV, IEV, and EEV
Chelsea M Byrd, Dennis E Hruby
Antiviral Research
|
September 4, 2007
Discovery and development of antiviral drugs for biodefense: experience of a small biotechnology company
Tove C Bolken, Dennis E Hruby
Biochemistry
|
June 30, 2004
Sequence-independent acylation of the vaccinia virus A-type inclusion protein
Jennifer D Yoder, Tsefang Chen, Dennis E Hruby
Future Virology
|
August 13, 2011
Development of the small-molecule antiviral ST-246 as a smallpox therapeutic
Douglas W Grosenbach, Robert Jordan, Dennis E Hruby
Biotechniques
|
May 22, 2002
BiZyme: a novel fusion protein-mediating selection of vaccinia virus recombinants by fluorescence and antibiotic resistance
Scott G Hansen, Torrey A Cope, Dennis E Hruby
Journal of Virology
|
August 7, 2002
The vaccinia virus I7L gene product is the core protein proteinase
Chelsea M Byrd, Tove' C Bolken, Dennis E Hruby
Virology Journal
|
September 2, 2006
Analysis of vaccinia virus temperature-sensitive I7L mutants reveals two potential functional domains
Megan J Moerdyk, Chelsea M Byrd, Dennis E Hruby
Journal of Virology
|
September 27, 2003
Molecular dissection of the vaccinia virus I7L core protein proteinase
Chelsea M Byrd, Tove' C Bolken, Dennis E Hruby
Virology Journal
|
March 1, 2006
Mutational analysis of the potential catalytic residues of the VV G1L metalloproteinase
Kady M Honeychurch, Chelsea M Byrd, Dennis E Hruby
Page
of 9